Results 81 to 90 of about 151,127 (351)
Purpose: Persistent levels of prostate-specific antigen (PSA) is a poor prognostic factor for recurrence after radical prostatectomy (RP). We investigated the impact of the percentage of residual PSA (%rPSA) [(post-/preoperative PSA)×100], representing
Dan Bee Lee +6 more
doaj +1 more source
Androgen receptor phosphorylation status at serine 578 predicts poor outcome in prostate cancer patients [PDF]
Purpose: Prostate cancer growth is dependent upon androgen receptor (AR) activation, regulated via phosphorylation. Protein kinase C (PKC) is one kinase that can mediate AR phosphorylation. This study aimed to establish if AR phosphorylation by PKC is of
Edwards, J. +7 more
core +1 more source
Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes
ABSTRACT Background To independently assess data for recently reported genes—BIK, SAMHD1, FAM111A, and AOX1—in which rare variants have been associated with prostate cancer (PCa) risk and aggressiveness. Methods The study included 4448 PCa cases from Johns Hopkins School of Medicine and 103,221 population‐based controls from the Genome Aggregation ...
Christian P. Pavlovich +11 more
wiley +1 more source
Survival of patients with prostate cancer and normal PSA levels treated by radical prostatectomy
INTRODUCTION: The unpredictability of prostate cancer has become a daily challenge for the urologist, with different strategies being required to manage these cases.
Marcos F. Dall'oglio +5 more
doaj +1 more source
ABSTRACT Background EAU guidelines recommend salvage radical prostatectomy (sRP) only in highly selected patients with recurrent prostate cancer in experienced centers. Methods The Junior ERUS/Young Academic Urologist Working Group on Robot‐Assisted Surgery conducted a multicentric project to investigate biochemical recurrence‐free (BCR), metastases ...
Mike Wenzel +30 more
wiley +1 more source
The primacy of multiparametric MRI in men with suspected prostate cancer [PDF]
Background: Multiparametric MRI (mpMRI) became recognised in investigating those with suspected prostate cancer between 2010 and 2012; in the USA, the preventative task force moratorium on PSA screening was a strong catalyst. In a few short years, it has
Logager, V. +5 more
core +5 more sources
ABSTRACT Background Prostate‐specific antigen (PSA) remains the standard biomarker for prostate cancer (PCa) detection, but its limited specificity—particularly in the 3–10 ng/mL range—leads to overdiagnosis and unnecessary biopsies. Including multiparameteric MRI (mpMRI) helps to reduce the number of PSA‐false‐positive biopsies, but there is still a ...
Kambiz Rahbar +4 more
wiley +1 more source
Pathology of a Canine Model of Localized Prostate Carcinoma
ABSTRACT Background Dogs spontaneously develop prostate carcinoma (PC) and share prostate gland anatomy, physiology, and size to men. Over the last 15 years, we have developed and refined a canine model of focal PC to evaluate therapeutic‐diagnostic (theranostic) interventions.
Nathan K. Hoggard +17 more
wiley +1 more source
Background: Prostate cancer (PCa) is the most common cancer in men in the UK. Patients with intermediate-risk, clinically localised disease are offered radical treatments such as surgery or radiotherapy, which can result in severe side effects.
Freddie C Hamdy +21 more
doaj +1 more source
Diagnostic Value of Micro‐Ultrasound in Identifying Local Recurrence After Radical Prostatectomy
ABSTRACT Purpose The limited resolution of standard transrectal ultrasound (TRUS) has made it difficult to perform biopsies of the prostate bed in cases of suspected local recurrence following radical prostatectomy. The aim of this study was to benchmark the performance of using high resolution micro‐ultrasound (microUS) in place of standard TRUS for ...
Basil Kaufmann +11 more
wiley +1 more source

